Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Neurology
Disease Category: Migraine (Pediatric)
Trial Information
A Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents
This study is to evaluate the safety and tolerability of a
combination tablet for migraines in adolescents.
Patient Inclusion Criteria:
- Adolescents between the ages of 12 and 17
- Have Migraines with or without aura
- History of migraines for at least 6 months.
Lovelace Scientific Resources - NV
1037 Whitney Ranch Dr.
Henderson, NV 89014
Phone: 1-888-315-9156
EMail: tmontoya@lrri.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
